Margaret A Potts

7PUBLICATIONS
30CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsElectrochemical energy storage and conversionHaematological tumoursModelling and simulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 18, 2026
A high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivo.

|Aug 21, 2025
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma.

Margaret A Potts, Shinsuke Mizutani, Yexuan Deng

|Jan 30, 2025
Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening.

Wei Jin, Yexuan Deng, John E La Marca

|Dec 19, 2023
Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice.

Margs S Brennan, Kerstin Brinkmann, Gerard Romero Sola

|Mar 09, 2023
Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis.

Margaret A Potts, Shinsuke Mizutani, Alexandra L Garnham

|Aug 12, 2022
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.

Yexuan Deng, Sarah T Diepstraten, Margaret A Potts

Pageof 2

Frequent Collaborators

7 joint publications

Marco J Herold

4 joint publications

Andreas Strasser

3 joint publications

Martin Pal

3 joint publications

Jane E Visvader